← All stocks

Organogenesis Holdings Inc.

ORGO Net selling
CIK 0001661181 #3789 in the set updated 21 Sep 2026
Bought (120 mo)
$67.61M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$173.65M
$0.00 on a plan · $12.34M straight out of an exercise
Sold at will
$161.31M
62 of 83 sales
Net
−$106.04M
−$93.70M against sales at will

By person

31 insiders · 170 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
NUSSDORF GLENN H
Director
$4.58M (10)
$67.10M (8)
−$62.53M
139,543,009
$372.41M
−0.2%
Ades Alan A.
Director
$3.23M (7)
$64.41M (2)
−$61.17M
238,812,503
$637.34M
+7.2%
Avista Capital Managing Member IV, LLC entity
Director
$57.41M (20)
+$57.41M
71,538
$190.92K
−94.8%
Gillheeney Gary S.
President and CEO
$18.17M (34) scheduled
−$18.17M
4,629,012
$12.35M
+1,068%
ERANI ALBERT
10% owner
$10.46M (20)
−$10.46M
51,585,403
$137.67M
−23.8%
Albert Erani Family Trust dated 12/29/2012 entity
10% owner
$6.34M (4)
−$6.34M
118,896,054
$317.31M
−0.3%
Wisdom Starr
10% owner
$5.96M (11)
−$5.96M
20,000
$53.38K
−96.6%
Montecalvo Antonio S.
Vice President, Health Policy
$902.69K (2) scheduled
−$902.69K
234,645
$626.22K
+2,666%
MACKIE WAYNE D
Director
$808.27K (9)
+$808.27K
211,800
$565.25K
Freedman Lori
Chief Admin. and Legal Officer
$725.29K (3)
+$725.29K
1,023,355
$2.73M
KATZ MICHAEL W
10% owner
$487.14K (20)
+$487.14K
76,382
$203.85K
+2,580%
GN 2016 Organo 10-Year GRAT u/a/d September 30, 2016
10% owner
$248.25K (1)
+$248.25K
59,448,027
$158.65M
0.0%
Erani Dennis
10% owner
$172.74K (1)
−$172.74K
127,625,238
$340.61M
0.0%
Driscoll Michael Joseph
Director
$50.69K (2)
$127.54K (1)
−$76.85K
225,707
$602.37K
Leibowitz Arthur S
Director
$71.23K (4)
+$71.23K
291,014
$776.66K
RED Holdings, LLC entity
10% owner
118,896,054
$317.31M
0.0%
Dennis Erani 2012 Issue Trust dated 12/20/12 entity
10% owner
118,896,054
$317.31M
0.0%
GN 2016 Family Trust u/a/d August 12, 2016 entity
10% owner
51,085,403
$136.34M
−1.9%
Burgstahler David F
President & CEO
15,561,473
$41.53M
Bilbo Patrick
Chief Operating Officer
1,249,785
$3.34M
+1,952%
Grow Brian
Chief Commercial Officer
900,817
$2.40M
+178,634%
Francisco David
Chief Financial Officer
731,020
$1.95M
Cavorsi Robert
Vice President, Strategy
275,524
$735.32K
+96.5%
Duraibabu Prathyusha
Director
247,047
$659.32K
Giacomin Jon L
Director
241,026
$643.25K
Quintero Gilberto
Director
239,073
$638.04K
Korfin Michele Ilene
Director
239,073
$638.04K
Lustig Garrett
Director
125,742
$335.58K
+359.9%
Tamaroff Joshua Alexander
Director
30,364
$81.04K
Cunningham Timothy M.
Chief Financial Officer
27,847
$74.32K
Hagopian Henry III
Interim CFO
12,073
$32.22K
+779.3%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Insider
Date
Role
Action
Shares
Price
Amount
Grow Brian
11 Aug 2025
Chief Commercial Officer
Exercised, kept
4,060
$2.47
$10.03K
Grow Brian
10 Jan 2025
Chief Commercial Officer
Exercised, kept
958
$1.24
$1.19K
Gillheeney Gary S.
5 Dec 2024
President and CEO
Exercised, kept
1,067,245
$0.99
$1.06M
Bilbo Patrick
28 Mar 2024
Chief Operating Officer
Exercised, kept
152,250
$1.18
$179.66K
Grow Brian
20 Aug 2022
Chief Commercial Officer
Exercised, kept
805
$1.46
$1.18K
Gillheeney Gary S.
30 Jun 2022
President and CEO
Exercised, kept
505,050
$0.99
$500.00K
Bilbo Patrick
10 Nov 2021
Chief Operating Officer
Exercised, kept
30,450
$1.44
$43.85K
Grow Brian
14 Apr 2020
Chief Commercial Officer
Exercised, kept
1,150
$1.70
$1.96K
Gillheeney Gary S.
5 Feb 2020
President and CEO
Exercised, kept
397,900
$1.70
$676.43K
Montecalvo Antonio S.
21 Jan 2020
VP Health Policy & Contracting
Exercised, kept
30,450
$1.70
$51.77K
Grow Brian
1 Oct 2019
Chief Commercial Officer
Exercised, kept
667
$1.70
$1.13K

What was left out

Form 4 filings counted 271
Amendments (4/A) skipped 10
Filings about a different issuer 0
Unreadable filings 0
Joint filings 56
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 21
Sales at will 62
Transactions with no price 1
Shares from compensation/vesting 287,940,282
Sales filed before the plan box existed 42
History held since 29 Nov 2016